Drug-price Transparency for Consumers Act of 2023

[AI summary unavailable — showing source text] [Congressional Bills 118th Congress] [From the U.S. Government Publishing Office] [H.R. 5958 Introduced in House (IH)] <DOC> 118th CONGRESS 1st Session H. R. 5958 To amend title XI of the Social Security Act to require that direct-to- consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information. _______________________________________________________________________ IN THE HOUSE OF REPRESENTATIVES October 13, 2023 Ms. Spanberger (for herself and Mr. Nunn of Iowa) introduced the following bill October 25, 2023 Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned _______________________________________________________________________ A BILL To amend title XI of the Social Security Act to require that direct-to- consumer advertisements for drugs and biologicals include an appropriate disclosure of pricing information. Be it enacted by the Senate and House of Representatives of the United States of America in Congress ass…